19-51581511-G-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000262259.7(ZNF175):c.193G>T(p.Ala65Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000893 in 1,612,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000262259.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF175 | NM_007147.4 | c.193G>T | p.Ala65Ser | missense_variant | 3/5 | ENST00000262259.7 | NP_009078.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF175 | ENST00000262259.7 | c.193G>T | p.Ala65Ser | missense_variant | 3/5 | 1 | NM_007147.4 | ENSP00000262259 | P1 | |
ZNF175 | ENST00000436511.2 | c.193G>T | p.Ala65Ser | missense_variant | 2/4 | 2 | ENSP00000440578 | |||
ZNF175 | ENST00000596504.1 | c.193G>T | p.Ala65Ser | missense_variant | 3/3 | 2 | ENSP00000470922 | |||
ZNF175 | ENST00000600460.1 | n.144G>T | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249364Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134672
GnomAD4 exome AF: 0.0000979 AC: 143AN: 1460340Hom.: 0 Cov.: 31 AF XY: 0.0000922 AC XY: 67AN XY: 726298
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74328
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at